[
  {
    "ts": "2025-12-12T13:47:31+00:00",
    "headline": "Stock Market Today: Dow Rises But Nasdaq, AI Stocks Falter As Broadcom Plunges On Earnings (Live Coverage)",
    "summary": "Stock Market Today: The Dow Jones index rose Friday, but AI stocks faltered as Broadcom stock plunged on earnings.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-ai-stocks-broadcom-avgo-stock/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "d47724df-cef1-316a-90ff-29627f1cafc9",
      "content": {
        "id": "d47724df-cef1-316a-90ff-29627f1cafc9",
        "contentType": "STORY",
        "title": "Stock Market Today: Dow Rises But Nasdaq, AI Stocks Falter As Broadcom Plunges On Earnings (Live Coverage)",
        "description": "",
        "summary": "Stock Market Today: The Dow Jones index rose Friday, but AI stocks faltered as Broadcom stock plunged on earnings.",
        "pubDate": "2025-12-12T13:47:31Z",
        "displayTime": "2025-12-12T13:47:31Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d47724df-cef1-316a-90ff-29627f1cafc9/stock-market-today-dow-rises.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/54efffaed4eb0f480c982a3545585fe5",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tJUArCiQBZ1_h3EpW.d2aw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/54efffaed4eb0f480c982a3545585fe5.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lC4kYCJCNsHv8IDGvNiQ.g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/54efffaed4eb0f480c982a3545585fe5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-ai-stocks-broadcom-avgo-stock/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "COST"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "LULU"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "QQQ"
            },
            {
              "symbol": "SPY"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "AAPL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T13:45:00+00:00",
    "headline": "Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)",
    "summary": "RAHWAY, N.J., December 12, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the approval of an expanded indication for WINREVAIR™ (sotatercept), in combination with other pulmonary arterial hypertension (PAH) therapies, for the treatment of PAH in adult patients with WHO Functional Class (FC) II, III, and IV based on the Phase 3 ZENITH study. The cu",
    "url": "https://finance.yahoo.com/news/merck-receives-positive-eu-chmp-134500454.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "b694046e-12ab-3891-be91-8d4d5c462f89",
      "content": {
        "id": "b694046e-12ab-3891-be91-8d4d5c462f89",
        "contentType": "STORY",
        "title": "Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)",
        "description": "",
        "summary": "RAHWAY, N.J., December 12, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the approval of an expanded indication for WINREVAIR™ (sotatercept), in combination with other pulmonary arterial hypertension (PAH) therapies, for the treatment of PAH in adult patients with WHO Functional Class (FC) II, III, and IV based on the Phase 3 ZENITH study. The cu",
        "pubDate": "2025-12-12T13:45:00Z",
        "displayTime": "2025-12-12T13:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/f7a2532829128065e2649a2fe11297f6",
          "originalWidth": 480,
          "originalHeight": 217,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BfOto2gpKgDygL2QgZkd1A--~B/aD0yMTc7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f7a2532829128065e2649a2fe11297f6.cf.webp",
              "width": 480,
              "height": 217,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/D4D3..tbmFN5iiWuTB6krA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f7a2532829128065e2649a2fe11297f6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-receives-positive-eu-chmp-134500454.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-receives-positive-eu-chmp-134500454.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T15:11:18+00:00",
    "headline": "Does WINREVAIR’s CHMP-Backed Label Expansion Shift The Bull Case For Merck (MRK)?",
    "summary": "In early December 2025, Merck reported that the EMA’s Committee for Medicinal Products for Human Use recommended expanding WINREVAIR’s EU indication to cover adults with pulmonary arterial hypertension in WHO Functional Class II, III and IV, based on Phase 3 ZENITH data in high‑risk patients. This positive opinion, following recent U.S. label updates, strengthens WINREVAIR’s profile as a first‑in‑class activin signaling inhibitor and could broaden its clinical and commercial reach in severe...",
    "url": "https://finance.yahoo.com/news/does-winrevair-chmp-backed-label-151118381.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b7847394-8802-3d7e-9bfb-f7ab9cef8143",
      "content": {
        "id": "b7847394-8802-3d7e-9bfb-f7ab9cef8143",
        "contentType": "STORY",
        "title": "Does WINREVAIR’s CHMP-Backed Label Expansion Shift The Bull Case For Merck (MRK)?",
        "description": "",
        "summary": "In early December 2025, Merck reported that the EMA’s Committee for Medicinal Products for Human Use recommended expanding WINREVAIR’s EU indication to cover adults with pulmonary arterial hypertension in WHO Functional Class II, III and IV, based on Phase 3 ZENITH data in high‑risk patients. This positive opinion, following recent U.S. label updates, strengthens WINREVAIR’s profile as a first‑in‑class activin signaling inhibitor and could broaden its clinical and commercial reach in severe...",
        "pubDate": "2025-12-12T15:11:18Z",
        "displayTime": "2025-12-12T15:11:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kA84g.s9IO2ClCgTX6BCgg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DmY770n7xz5DXLM6ZHLmxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/does-winrevair-chmp-backed-label-151118381.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/does-winrevair-chmp-backed-label-151118381.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T15:03:00+00:00",
    "headline": "Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?",
    "summary": "Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytruda's 2028 LOE nears.",
    "url": "https://finance.yahoo.com/news/mrks-drugs-pipeline-help-navigate-150300881.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "904af40f-544f-38da-bcdc-fa4f0dda6e03",
      "content": {
        "id": "904af40f-544f-38da-bcdc-fa4f0dda6e03",
        "contentType": "STORY",
        "title": "Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?",
        "description": "",
        "summary": "Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytruda's 2028 LOE nears.",
        "pubDate": "2025-12-12T15:03:00Z",
        "displayTime": "2025-12-12T15:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RRg0vYpNavphT7S8O9jT7w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hIkvgr9e5vaptAEV_vkcVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mrks-drugs-pipeline-help-navigate-150300881.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mrks-drugs-pipeline-help-navigate-150300881.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]